Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Electronic Toolkit Improves Care of Heart Patients

By HospiMedica International staff writers
Posted on 25 May 2011
A quality improvement toolkit assists hospital medical, surgical, pharmacy, and nursing staff to conduct an audit of the discharge management of patients with acute coronary syndromes (ACS). More...


The discharge management of acute coronary syndromes (DMACS) drug use evaluation (DUE) audit tool is a standalone Microsoft Windows application that can be easily downloaded and used by hospital pharmacists, nurses, cardiology staff, quality managers, and graduates. The toolkit was created following an Australian national quality improvement project in 49 Australian public and private hospitals. The toolkit contains an electronic audit tool for data collection and summary reporting, resources to support the DUE process, and educational resources to assist healthcare professionals improve their knowledge and implement learning about the discharge management of patients with ACS.

The DMACS e-DUE enables data entry, automated analysis of data and generation of a summary report on selected key measures following data collection. Parameters entered into the audit tool, which is designed as an electronic form worksheet, include demographic data, diagnosis, co-morbidites, drug use, and discharge follow-up. An important part of the process is compulsory telephone follow-up of all patients and reevaluation of medications and compliance. The summary report helps identify aspects of the discharge management of ACS requiring improvement, including outcomes, processes, and systems of care. The DMACS e-DUE toolkit is available for free download from the Australian National Prescribing Service (NPS; Sydney, Australia).

"When patients feel supported they are more likely to stick with their treatment plans. This new tool will help ensure optimal care at and following discharge, and promote better communication between hospital staff, patients, carers, and community health providers," said associate professor of pharmacy Danielle Stowasser, MD, of the University of Queensland (Brisbane, Australia).

ACS include a broad spectrum of clinical presentations, which may include acute myocardial infarction (MI), ST-segment elevation MI, non-ST-segment elevation MI, enzyme/troponin-diagnosed MI, late electrocardiogram (ECG)-diagnosed MI, or unstable angina. Clinical presentation may include symptoms of chest discomfort at rest for a prolonged period, recurrent chest discomfort, or discomfort associated with syncope or acute heart failure. Other presentations of ACS may include back, neck, arm or epigastric pain, chest tightness, dyspnea, diaphoresis, and nausea and vomiting.

Related Links:

Australian National Prescribing Service
University of Queensland



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.